Key Details
Annual ROE
-109.17%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
May 05, 2023Recent annual earnings:
Mar 10, 2022Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
07 Nov '22 Goldman Sachs
Neutral01 Sept '22 Goldman Sachs
Neutral05 July '22 Goldman Sachs
Buy24 May '22 Goldman Sachs
Buy22 Feb '22 Wedbush
Outperform11 Feb '22 Goldman Sachs
Buy09 Nov '20 Wedbush
Outperform09 Nov '20 Goldman Sachs
BuyScreeners with CDAK included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Codiak BioSciences doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
Codiak BioSciences files for bankruptcy, looks to sell off assets
CDAK
Market Watch27 March 2023
Codiak BioSciences Inc. CDAK, -4.56% said Monday that it has field for bankruptcy, and it looking to selloff of its assets to maximize the company's value. “The Board and management team have thoroughly assessed all of our strategic options and believe that this structured process represents the best possible solution for Codiak, taking into account our financial needs and the stage of our clinical and research programs,” the Massachusetts-based biopharmaceutical company said in a statement.
Why Is Codiak BioSciences (CDAK) Stock Down 52% Today?
CDAK
InvestorPlace27 March 2023
Codiak BioSciences (NASDAQ: CDAK ) stock is falling hard on Monday after the company announced plans for an asset sale through a Chapter 11 bankruptcy. According to a press release, Codiak BioSciences started the marketing process before entering into Chapter 11.
FAQ
- What is the primary business of Codiak BioSciences?
- What is the ticker symbol for Codiak BioSciences?
- Does Codiak BioSciences pay dividends?
- What sector is Codiak BioSciences in?
- What industry is Codiak BioSciences in?
- What country is Codiak BioSciences based in?
- When did Codiak BioSciences go public?
- Is Codiak BioSciences in the S&P 500?
- Is Codiak BioSciences in the NASDAQ 100?
- Is Codiak BioSciences in the Dow Jones?
- When was Codiak BioSciences's last earnings report?
- When does Codiak BioSciences report earnings?
- Should I buy Codiak BioSciences stock now?
What is the primary business of Codiak BioSciences?
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of various solid tumors. The company is also developing exoASO-STAT6, an antisense oligonucleotide targeting the STAT6 transcription factor; and exoVACC, a modular platform for constructing precision vaccines. It has a collaboration agreement with the Jazz Pharmaceuticals Ireland Limited, Sarepta Therapeutics, Inc., Kayla Therapeutics S.A.S., Washington University, Ragon Institute of MGH, MIT, and Harvard. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. On March 27, 2023, Codiak BioSciences, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
What is the ticker symbol for Codiak BioSciences?
The ticker symbol for Codiak BioSciences is NASDAQ:CDAK
Does Codiak BioSciences pay dividends?
No, Codiak BioSciences does not pay dividends
What sector is Codiak BioSciences in?
Codiak BioSciences is in the Healthcare sector
What industry is Codiak BioSciences in?
Codiak BioSciences is in the Biotechnology industry
What country is Codiak BioSciences based in?
Codiak BioSciences is headquartered in United States
When did Codiak BioSciences go public?
Codiak BioSciences's initial public offering (IPO) was on 14 October 2020
Is Codiak BioSciences in the S&P 500?
No, Codiak BioSciences is not included in the S&P 500 index
Is Codiak BioSciences in the NASDAQ 100?
No, Codiak BioSciences is not included in the NASDAQ 100 index
Is Codiak BioSciences in the Dow Jones?
No, Codiak BioSciences is not included in the Dow Jones index
When was Codiak BioSciences's last earnings report?
Codiak BioSciences's most recent earnings report was on 5 May 2023
When does Codiak BioSciences report earnings?
The date for Codiak BioSciences's next earnings report has not been announced yet
Should I buy Codiak BioSciences stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions